Tuesday 14 March 2017

Many Survivors Of Lymphoma Did Not Receive A Recommendation To Take Further Tests For Other Types Of Cancer

Many Survivors Of Lymphoma Did Not Receive A Recommendation To Take Further Tests For Other Types Of Cancer.
Many Hodgkin lymphoma survivors don't pull down recommended consolidation screening tests for other cancers, a supplementary inquiry finds. "Most Hodgkin lymphoma patients are cured, but they can be at risk many years later of developing unessential cancers or other late effects of their initial treatment. This is why value of follow-up care post-treatment is so important," principal investigator Dr David Hodgson, a emanation oncologist at the Princess Margaret Hospital Cancer Program in Toronto, Canada, said in a University Health Network word release.

He and his colleagues followed 2071 survivors for up to 15 years after Hodgkin lymphoma diagnosis and found that 62,5 percent were not screened for colorectal cancer, 32,3 percent were not screened for chest cancer, and 19,9 percent were not screened for cervical cancer. "Our results exhibit that the optimal backup care did not happen, even though most patients had visits with both a primary care provider and an oncologist in years two through five.

So there are opportunities to fix up post-treatment surveillance for relapse and late effects" of therapy for Hodgkin lymphoma, Hodgson explained in the news release. The researchers were specially alarmed to find that no screening was done in 87,1 percent of young women survivors who were at potentially cheerful risk of breast cancer because of the radiation therapy they had received for Hodgkin lymphoma.

The study also found that survivors had CT scans at a classify three times higher than that of the general population, sometimes up to 15 years after their endorse diagnosis. "It is not clear why the CT scans were ordered, but they certainly did not appear to be an efficacious way to detect relapse, particularly this long after treatment was finished".

Most Hodgkin lymphoma patients never bear a relapse, and those who do usually know that something is wrong before a doctor detects it, the con authors noted. "Oncologists need to advise their patients what symptoms should prompt them to seek medical heed - and physicians have to be able to evaluate them in a timely way to decide if imaging is needed" men who use mpfunguri. The boning up is published online and in the July print issue of the journal Cancer.

No comments:

Post a Comment